KERRI ZUKOSKY: Open Payments
NPI 1922138767 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 27 payments from 13 companies in 2025. Trend: 2023 $144 · 2024 $817 · 2025 $651
Food & beverage: $551Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $128 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| ABBVIE INC. | 5 | $87 |
| Organon LLC | 3 | $61 |
| GENZYME CORPORATION | 2 | $53 |
| UCB, Inc. | 2 | $52 |
| LEO Pharma Inc. | 2 | $48 |
| Journey Medical Corporation | 2 | $37 |
| Incyte Corporation | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, RINVOQ, OPZELURA, ADBRY, Rhapsido.
Industry payments across CO — which companies pay providers there.
